Churchill Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,180,380
Closed -$346M 117
2018
Q3
$346M Buy
2,180,380
+1,880,530
+627% +$285M 7.49% 2
2018
Q2
$42M Buy
299,850
+1,355
+0.5% +$186K 1.12% 17
2018
Q1
$39.7M Sell
298,495
-9,496
-3% -$1.3M 1.15% 13
2017
Q4
$38.4M Buy
307,991
+268,797
+686% +$33.2M 0.84% 15
2017
Q3
$4.86M Hold
39,194
0.12% 71
2017
Q2
$4.47M Buy
+39,194
New +$4.21M 0.12% 69
2015
Q3
Sell
-44,029
Closed -$5.46M 144
2015
Q2
$5.46M Buy
44,029
+244
+0.6% +$29.5K 0.19% 69
2015
Q1
$5.18M Sell
43,785
-6,219
-12% -$703K 0.18% 80
2014
Q4
$5.1M Sell
50,004
-17,690
-26% -$1.73M 0.2% 73
2014
Q3
$6.21M Sell
67,694
-1,019
-1% -$88.4K 0.26% 51
2014
Q2
$5.66M Sell
68,713
-9,824
-13% -$751K 0.26% 51
2014
Q1
$6.02M Sell
78,537
-232
-0.3% -$18.1K 0.24% 31
2013
Q4
$5.45M Buy
78,769
+883
+1% +$57.9K 0.21% 33
2013
Q3
$5.05M Sell
77,886
-2,323
-3% -$147K 0.26% 21
2013
Q2
$4.67M Buy
+80,209
New +$4.58M 0.22% 24

Other funds holding FBT

Churchill Management's FBT Position: Q4 2018 in Review

Churchill Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2018, closing a stake of 2,180,380 shares — an estimated $346M sold.

Churchill Management first reported a position in FBT in Q2 2013 and held it in 15 quarters. The position peaked at $346M in Q3 2018. 194 funds tracked by Wall St. Rank hold FBT as of Q4 2018.

  • Churchill Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2018 after selling out during the quarter.
  • Churchill Management sold 2,180,380 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2018, an estimated $346M.
  • Churchill Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 15 quarters.
  • Churchill Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $346M in Q3 2018.
  • 194 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2018.

Based on Churchill Management's 13F filing for Q4 2018, filed 15 Jan 2019.